- REPORT SUMMARY
- TABLE OF CONTENTS
-
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.The global colloids (blood plasma) industry is mature. The production of Human Albumin increase from 544.08 MT in 2010 to 805.38 MT in 2015, with an average growth rate of more than 9.60 %. The production of synthetic colloids increase from 42.03 Million Units in 2010 to 53.43 Million Units in 2015, with an average growth rate of more than 5.42 %. The production growth rate of hydroxyethyl starch colloid reduced obviously because Europe and USA banned the usage of HES solutions in patients with sepsis. At the same time, this stimulated the increase of growth rate in albumin colloids.The manufacturers and consumers of natural colloids and synthetic colloids are both concentrated in North America, Europe and China. North America is the largest manufacturer and consumer in natural colloids , however Europe occupies the largest share in the global synthetic market.
Colloids (Blood Plasma) market report explains the definition, types, applications, major countries, and major players of the Colloids (Blood Plasma) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Rongsheng Pharmaceutical
CTBB
Kanglepharm
Shandong Qidu Pharmaceutical
Shanghai Raas
Octapharma
Grifols
B Braun Medical
CSL Behring
Fresenius Kabi(China)
Fresenius Kabi
Shandong Hualu Pharmaceutical
CR Double-Crane
Minsheng Pharma
Shandong Hualu Pharmaceutical(China)
Kelun Group
Hualan Bio
Baxter
Boya Rongsheng
Kedrion
Axa parenterals
By Type:
Natural Type Colloids (Blood Plasma)
Synthetic Type Colloids (Blood Plasma)
By End-User:
Extensive Burns
Massive Blood or Plasma Loss
Hypovolemic Shock
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Colloids (Blood Plasma) Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Colloids (Blood Plasma) Outlook to 2028- Original Forecasts
-
2.2 Colloids (Blood Plasma) Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Colloids (Blood Plasma) Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Colloids (Blood Plasma) Market- Recent Developments
-
6.1 Colloids (Blood Plasma) Market News and Developments
-
6.2 Colloids (Blood Plasma) Market Deals Landscape
7 Colloids (Blood Plasma) Raw Materials and Cost Structure Analysis
-
7.1 Colloids (Blood Plasma) Key Raw Materials
-
7.2 Colloids (Blood Plasma) Price Trend of Key Raw Materials
-
7.3 Colloids (Blood Plasma) Key Suppliers of Raw Materials
-
7.4 Colloids (Blood Plasma) Market Concentration Rate of Raw Materials
-
7.5 Colloids (Blood Plasma) Cost Structure Analysis
-
7.5.1 Colloids (Blood Plasma) Raw Materials Analysis
-
7.5.2 Colloids (Blood Plasma) Labor Cost Analysis
-
7.5.3 Colloids (Blood Plasma) Manufacturing Expenses Analysis
8 Global Colloids (Blood Plasma) Import and Export Analysis (Top 10 Countries)
-
8.1 Global Colloids (Blood Plasma) Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Colloids (Blood Plasma) Export by Region (Top 10 Countries) (2017-2028)
9 Global Colloids (Blood Plasma) Market Outlook by Types and Applications to 2022
-
9.1 Global Colloids (Blood Plasma) Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Natural Type Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Synthetic Type Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
9.2 Global Colloids (Blood Plasma) Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Extensive Burns Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Massive Blood or Plasma Loss Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Hypovolemic Shock Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Colloids (Blood Plasma) Market Analysis and Outlook till 2022
-
10.1 Global Colloids (Blood Plasma) Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Colloids (Blood Plasma) Consumption (2017-2022)
-
10.2.2 Canada Colloids (Blood Plasma) Consumption (2017-2022)
-
10.2.3 Mexico Colloids (Blood Plasma) Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Colloids (Blood Plasma) Consumption (2017-2022)
-
10.3.2 UK Colloids (Blood Plasma) Consumption (2017-2022)
-
10.3.3 Spain Colloids (Blood Plasma) Consumption (2017-2022)
-
10.3.4 Belgium Colloids (Blood Plasma) Consumption (2017-2022)
-
10.3.5 France Colloids (Blood Plasma) Consumption (2017-2022)
-
10.3.6 Italy Colloids (Blood Plasma) Consumption (2017-2022)
-
10.3.7 Denmark Colloids (Blood Plasma) Consumption (2017-2022)
-
10.3.8 Finland Colloids (Blood Plasma) Consumption (2017-2022)
-
10.3.9 Norway Colloids (Blood Plasma) Consumption (2017-2022)
-
10.3.10 Sweden Colloids (Blood Plasma) Consumption (2017-2022)
-
10.3.11 Poland Colloids (Blood Plasma) Consumption (2017-2022)
-
10.3.12 Russia Colloids (Blood Plasma) Consumption (2017-2022)
-
10.3.13 Turkey Colloids (Blood Plasma) Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Colloids (Blood Plasma) Consumption (2017-2022)
-
10.4.2 Japan Colloids (Blood Plasma) Consumption (2017-2022)
-
10.4.3 India Colloids (Blood Plasma) Consumption (2017-2022)
-
10.4.4 South Korea Colloids (Blood Plasma) Consumption (2017-2022)
-
10.4.5 Pakistan Colloids (Blood Plasma) Consumption (2017-2022)
-
10.4.6 Bangladesh Colloids (Blood Plasma) Consumption (2017-2022)
-
10.4.7 Indonesia Colloids (Blood Plasma) Consumption (2017-2022)
-
10.4.8 Thailand Colloids (Blood Plasma) Consumption (2017-2022)
-
10.4.9 Singapore Colloids (Blood Plasma) Consumption (2017-2022)
-
10.4.10 Malaysia Colloids (Blood Plasma) Consumption (2017-2022)
-
10.4.11 Philippines Colloids (Blood Plasma) Consumption (2017-2022)
-
10.4.12 Vietnam Colloids (Blood Plasma) Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Colloids (Blood Plasma) Consumption (2017-2022)
-
10.5.2 Colombia Colloids (Blood Plasma) Consumption (2017-2022)
-
10.5.3 Chile Colloids (Blood Plasma) Consumption (2017-2022)
-
10.5.4 Argentina Colloids (Blood Plasma) Consumption (2017-2022)
-
10.5.5 Venezuela Colloids (Blood Plasma) Consumption (2017-2022)
-
10.5.6 Peru Colloids (Blood Plasma) Consumption (2017-2022)
-
10.5.7 Puerto Rico Colloids (Blood Plasma) Consumption (2017-2022)
-
10.5.8 Ecuador Colloids (Blood Plasma) Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Colloids (Blood Plasma) Consumption (2017-2022)
-
10.6.2 Kuwait Colloids (Blood Plasma) Consumption (2017-2022)
-
10.6.3 Oman Colloids (Blood Plasma) Consumption (2017-2022)
-
10.6.4 Qatar Colloids (Blood Plasma) Consumption (2017-2022)
-
10.6.5 Saudi Arabia Colloids (Blood Plasma) Consumption (2017-2022)
-
10.6.6 United Arab Emirates Colloids (Blood Plasma) Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Colloids (Blood Plasma) Consumption (2017-2022)
-
10.7.2 South Africa Colloids (Blood Plasma) Consumption (2017-2022)
-
10.7.3 Egypt Colloids (Blood Plasma) Consumption (2017-2022)
-
10.7.4 Algeria Colloids (Blood Plasma) Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Colloids (Blood Plasma) Consumption (2017-2022)
-
10.8.2 New Zealand Colloids (Blood Plasma) Consumption (2017-2022)
11 Global Colloids (Blood Plasma) Competitive Analysis
-
11.1 Rongsheng Pharmaceutical
-
11.1.1 Rongsheng Pharmaceutical Company Details
-
11.1.2 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Main Business and Markets Served
-
11.1.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 CTBB
-
11.2.1 CTBB Company Details
-
11.2.2 CTBB Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 CTBB Colloids (Blood Plasma) Main Business and Markets Served
-
11.2.4 CTBB Colloids (Blood Plasma) Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Kanglepharm
-
11.3.1 Kanglepharm Company Details
-
11.3.2 Kanglepharm Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Kanglepharm Colloids (Blood Plasma) Main Business and Markets Served
-
11.3.4 Kanglepharm Colloids (Blood Plasma) Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Shandong Qidu Pharmaceutical
-
11.4.1 Shandong Qidu Pharmaceutical Company Details
-
11.4.2 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Main Business and Markets Served
-
11.4.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Shanghai Raas
-
11.5.1 Shanghai Raas Company Details
-
11.5.2 Shanghai Raas Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Shanghai Raas Colloids (Blood Plasma) Main Business and Markets Served
-
11.5.4 Shanghai Raas Colloids (Blood Plasma) Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Octapharma
-
11.6.1 Octapharma Company Details
-
11.6.2 Octapharma Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Octapharma Colloids (Blood Plasma) Main Business and Markets Served
-
11.6.4 Octapharma Colloids (Blood Plasma) Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Grifols
-
11.7.1 Grifols Company Details
-
11.7.2 Grifols Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Grifols Colloids (Blood Plasma) Main Business and Markets Served
-
11.7.4 Grifols Colloids (Blood Plasma) Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 B Braun Medical
-
11.8.1 B Braun Medical Company Details
-
11.8.2 B Braun Medical Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 B Braun Medical Colloids (Blood Plasma) Main Business and Markets Served
-
11.8.4 B Braun Medical Colloids (Blood Plasma) Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 CSL Behring
-
11.9.1 CSL Behring Company Details
-
11.9.2 CSL Behring Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 CSL Behring Colloids (Blood Plasma) Main Business and Markets Served
-
11.9.4 CSL Behring Colloids (Blood Plasma) Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Fresenius Kabi(China)
-
11.10.1 Fresenius Kabi(China) Company Details
-
11.10.2 Fresenius Kabi(China) Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Fresenius Kabi(China) Colloids (Blood Plasma) Main Business and Markets Served
-
11.10.4 Fresenius Kabi(China) Colloids (Blood Plasma) Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Fresenius Kabi
-
11.11.1 Fresenius Kabi Company Details
-
11.11.2 Fresenius Kabi Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Fresenius Kabi Colloids (Blood Plasma) Main Business and Markets Served
-
11.11.4 Fresenius Kabi Colloids (Blood Plasma) Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Shandong Hualu Pharmaceutical
-
11.12.1 Shandong Hualu Pharmaceutical Company Details
-
11.12.2 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Main Business and Markets Served
-
11.12.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 CR Double-Crane
-
11.13.1 CR Double-Crane Company Details
-
11.13.2 CR Double-Crane Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 CR Double-Crane Colloids (Blood Plasma) Main Business and Markets Served
-
11.13.4 CR Double-Crane Colloids (Blood Plasma) Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Minsheng Pharma
-
11.14.1 Minsheng Pharma Company Details
-
11.14.2 Minsheng Pharma Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Minsheng Pharma Colloids (Blood Plasma) Main Business and Markets Served
-
11.14.4 Minsheng Pharma Colloids (Blood Plasma) Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Shandong Hualu Pharmaceutical(China)
-
11.15.1 Shandong Hualu Pharmaceutical(China) Company Details
-
11.15.2 Shandong Hualu Pharmaceutical(China) Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Shandong Hualu Pharmaceutical(China) Colloids (Blood Plasma) Main Business and Markets Served
-
11.15.4 Shandong Hualu Pharmaceutical(China) Colloids (Blood Plasma) Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Kelun Group
-
11.16.1 Kelun Group Company Details
-
11.16.2 Kelun Group Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Kelun Group Colloids (Blood Plasma) Main Business and Markets Served
-
11.16.4 Kelun Group Colloids (Blood Plasma) Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Hualan Bio
-
11.17.1 Hualan Bio Company Details
-
11.17.2 Hualan Bio Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Hualan Bio Colloids (Blood Plasma) Main Business and Markets Served
-
11.17.4 Hualan Bio Colloids (Blood Plasma) Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Baxter
-
11.18.1 Baxter Company Details
-
11.18.2 Baxter Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Baxter Colloids (Blood Plasma) Main Business and Markets Served
-
11.18.4 Baxter Colloids (Blood Plasma) Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Boya Rongsheng
-
11.19.1 Boya Rongsheng Company Details
-
11.19.2 Boya Rongsheng Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Boya Rongsheng Colloids (Blood Plasma) Main Business and Markets Served
-
11.19.4 Boya Rongsheng Colloids (Blood Plasma) Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Kedrion
-
11.20.1 Kedrion Company Details
-
11.20.2 Kedrion Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Kedrion Colloids (Blood Plasma) Main Business and Markets Served
-
11.20.4 Kedrion Colloids (Blood Plasma) Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 Axa parenterals
-
11.21.1 Axa parenterals Company Details
-
11.21.2 Axa parenterals Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 Axa parenterals Colloids (Blood Plasma) Main Business and Markets Served
-
11.21.4 Axa parenterals Colloids (Blood Plasma) Product Portfolio
-
11.21.5 Recent Research and Development Strategies
12 Global Colloids (Blood Plasma) Market Outlook by Types and Applications to 2028
-
12.1 Global Colloids (Blood Plasma) Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Natural Type Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Synthetic Type Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Colloids (Blood Plasma) Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Extensive Burns Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Massive Blood or Plasma Loss Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Hypovolemic Shock Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Colloids (Blood Plasma) Market Analysis and Outlook to 2028
-
13.1 Global Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.2.2 Canada Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.2.3 Mexico Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.3.2 UK Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.3.3 Spain Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.3.4 Belgium Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.3.5 France Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.3.6 Italy Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.3.7 Denmark Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.3.8 Finland Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.3.9 Norway Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.3.10 Sweden Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.3.11 Poland Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.3.12 Russia Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.3.13 Turkey Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.4.2 Japan Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.4.3 India Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.4.4 South Korea Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.4.8 Thailand Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.4.9 Singapore Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.4.11 Philippines Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.5.2 Colombia Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.5.3 Chile Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.5.4 Argentina Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.5.6 Peru Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.6.3 Oman Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.6.4 Qatar Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.7.2 South Africa Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.7.3 Egypt Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.7.4 Algeria Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Colloids (Blood Plasma) Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Colloids (Blood Plasma) Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Colloids (Blood Plasma)
-
Figure of Colloids (Blood Plasma) Picture
-
Table Global Colloids (Blood Plasma) Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Colloids (Blood Plasma) Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Natural Type Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Global Synthetic Type Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Global Extensive Burns Consumption and Growth Rate (2017-2022)
-
Figure Global Massive Blood or Plasma Loss Consumption and Growth Rate (2017-2022)
-
Figure Global Hypovolemic Shock Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Colloids (Blood Plasma) Consumption by Country (2017-2022)
-
Table North America Colloids (Blood Plasma) Consumption by Country (2017-2022)
-
Figure United States Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Canada Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Mexico Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Table Europe Colloids (Blood Plasma) Consumption by Country (2017-2022)
-
Figure Germany Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure UK Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Spain Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Belgium Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure France Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Italy Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Denmark Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Finland Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Norway Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Sweden Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Poland Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Russia Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Turkey Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Table APAC Colloids (Blood Plasma) Consumption by Country (2017-2022)
-
Figure China Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Japan Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure India Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure South Korea Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Thailand Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Singapore Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Philippines Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Table South America Colloids (Blood Plasma) Consumption by Country (2017-2022)
-
Figure Brazil Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Colombia Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Chile Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Argentina Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Peru Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Table GCC Colloids (Blood Plasma) Consumption by Country (2017-2022)
-
Figure Bahrain Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Oman Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Qatar Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Table Africa Colloids (Blood Plasma) Consumption by Country (2017-2022)
-
Figure Nigeria Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure South Africa Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Egypt Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure Algeria Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Table Oceania Colloids (Blood Plasma) Consumption by Country (2017-2022)
-
Figure Australia Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Colloids (Blood Plasma) Consumption and Growth Rate (2017-2022)
-
Table Rongsheng Pharmaceutical Company Details
-
Table Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Rongsheng Pharmaceutical Colloids (Blood Plasma) Main Business and Markets Served
-
Table Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio
-
Table CTBB Company Details
-
Table CTBB Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table CTBB Colloids (Blood Plasma) Main Business and Markets Served
-
Table CTBB Colloids (Blood Plasma) Product Portfolio
-
Table Kanglepharm Company Details
-
Table Kanglepharm Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kanglepharm Colloids (Blood Plasma) Main Business and Markets Served
-
Table Kanglepharm Colloids (Blood Plasma) Product Portfolio
-
Table Shandong Qidu Pharmaceutical Company Details
-
Table Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Main Business and Markets Served
-
Table Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
-
Table Shanghai Raas Company Details
-
Table Shanghai Raas Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanghai Raas Colloids (Blood Plasma) Main Business and Markets Served
-
Table Shanghai Raas Colloids (Blood Plasma) Product Portfolio
-
Table Octapharma Company Details
-
Table Octapharma Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Octapharma Colloids (Blood Plasma) Main Business and Markets Served
-
Table Octapharma Colloids (Blood Plasma) Product Portfolio
-
Table Grifols Company Details
-
Table Grifols Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Colloids (Blood Plasma) Main Business and Markets Served
-
Table Grifols Colloids (Blood Plasma) Product Portfolio
-
Table B Braun Medical Company Details
-
Table B Braun Medical Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table B Braun Medical Colloids (Blood Plasma) Main Business and Markets Served
-
Table B Braun Medical Colloids (Blood Plasma) Product Portfolio
-
Table CSL Behring Company Details
-
Table CSL Behring Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Behring Colloids (Blood Plasma) Main Business and Markets Served
-
Table CSL Behring Colloids (Blood Plasma) Product Portfolio
-
Table Fresenius Kabi(China) Company Details
-
Table Fresenius Kabi(China) Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fresenius Kabi(China) Colloids (Blood Plasma) Main Business and Markets Served
-
Table Fresenius Kabi(China) Colloids (Blood Plasma) Product Portfolio
-
Table Fresenius Kabi Company Details
-
Table Fresenius Kabi Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fresenius Kabi Colloids (Blood Plasma) Main Business and Markets Served
-
Table Fresenius Kabi Colloids (Blood Plasma) Product Portfolio
-
Table Shandong Hualu Pharmaceutical Company Details
-
Table Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Main Business and Markets Served
-
Table Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
-
Table CR Double-Crane Company Details
-
Table CR Double-Crane Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table CR Double-Crane Colloids (Blood Plasma) Main Business and Markets Served
-
Table CR Double-Crane Colloids (Blood Plasma) Product Portfolio
-
Table Minsheng Pharma Company Details
-
Table Minsheng Pharma Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Minsheng Pharma Colloids (Blood Plasma) Main Business and Markets Served
-
Table Minsheng Pharma Colloids (Blood Plasma) Product Portfolio
-
Table Shandong Hualu Pharmaceutical(China) Company Details
-
Table Shandong Hualu Pharmaceutical(China) Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shandong Hualu Pharmaceutical(China) Colloids (Blood Plasma) Main Business and Markets Served
-
Table Shandong Hualu Pharmaceutical(China) Colloids (Blood Plasma) Product Portfolio
-
Table Kelun Group Company Details
-
Table Kelun Group Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kelun Group Colloids (Blood Plasma) Main Business and Markets Served
-
Table Kelun Group Colloids (Blood Plasma) Product Portfolio
-
Table Hualan Bio Company Details
-
Table Hualan Bio Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hualan Bio Colloids (Blood Plasma) Main Business and Markets Served
-
Table Hualan Bio Colloids (Blood Plasma) Product Portfolio
-
Table Baxter Company Details
-
Table Baxter Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Colloids (Blood Plasma) Main Business and Markets Served
-
Table Baxter Colloids (Blood Plasma) Product Portfolio
-
Table Boya Rongsheng Company Details
-
Table Boya Rongsheng Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boya Rongsheng Colloids (Blood Plasma) Main Business and Markets Served
-
Table Boya Rongsheng Colloids (Blood Plasma) Product Portfolio
-
Table Kedrion Company Details
-
Table Kedrion Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kedrion Colloids (Blood Plasma) Main Business and Markets Served
-
Table Kedrion Colloids (Blood Plasma) Product Portfolio
-
Table Axa parenterals Company Details
-
Table Axa parenterals Colloids (Blood Plasma) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Axa parenterals Colloids (Blood Plasma) Main Business and Markets Served
-
Table Axa parenterals Colloids (Blood Plasma) Product Portfolio
-
Figure Global Natural Type Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Synthetic Type Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Extensive Burns Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Massive Blood or Plasma Loss Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hypovolemic Shock Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colloids (Blood Plasma) Consumption Forecast by Country (2022-2028)
-
Table North America Colloids (Blood Plasma) Consumption Forecast by Country (2022-2028)
-
Figure United States Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Colloids (Blood Plasma) Consumption Forecast by Country (2022-2028)
-
Figure Germany Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Colloids (Blood Plasma) Consumption Forecast by Country (2022-2028)
-
Figure China Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Colloids (Blood Plasma) Consumption Forecast by Country (2022-2028)
-
Figure Brazil Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Colloids (Blood Plasma) Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Colloids (Blood Plasma) Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Colloids (Blood Plasma) Consumption Forecast by Country (2022-2028)
-
Figure Australia Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Colloids (Blood Plasma) Consumption Forecast and Growth Rate (2022-2028)
-